These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 20876678

  • 1. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A.
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [Abstract] [Full Text] [Related]

  • 2. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.
    Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, Herrera Hernandez L, Vrana JA, Theis JD, Quint PS, Dogan A, Nasr SH.
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1515-23. PubMed ID: 23704299
    [Abstract] [Full Text] [Related]

  • 3. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
    Nasr SH, Said SM, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Dispenzieri A, Buadi FK, Vrana JA, Theis JD, Dogan A, Leung N.
    Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
    [Abstract] [Full Text] [Related]

  • 4. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, Nasr SH.
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [Abstract] [Full Text] [Related]

  • 5. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
    Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJ, Spinner RJ, Mauermann ML, Bergen HR, Zeldenrust SR, Dogan A.
    Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
    [Abstract] [Full Text] [Related]

  • 6. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F, Delbes S, Sirac C, Pourreau F, Puyade M, Desport E, Jaccard A, Fermand JP, Touchard G.
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [Abstract] [Full Text] [Related]

  • 7. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M, Li X, Wang L, Yue S, Zhao B.
    BMC Nephrol; 2022 Apr 13; 23(1):144. PubMed ID: 35418036
    [Abstract] [Full Text] [Related]

  • 8. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S, Iwasaki C, Hatano M, Kametani F, Yazaki M, Nitta K, Nagata M.
    BMC Nephrol; 2018 Nov 22; 19(1):337. PubMed ID: 30466387
    [Abstract] [Full Text] [Related]

  • 9. Renal AH Amyloidosis Associated With a Truncated Immunoglobulin Heavy Chain Undetectable by Immunostaining.
    Manabe S, Hatano M, Yazaki M, Nitta K, Nagata M.
    Am J Kidney Dis; 2015 Dec 22; 66(6):1095-100. PubMed ID: 26362695
    [Abstract] [Full Text] [Related]

  • 10. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
    Kadota A, Iwaide S, Miyazaki S, Mitsui I, Machida N, Murakami T.
    Vet Pathol; 2020 Sep 22; 57(5):658-665. PubMed ID: 32880234
    [Abstract] [Full Text] [Related]

  • 11. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
    Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, Fervenza FC, Cornell LD, Fidler ME, Dogan A.
    Kidney Int; 2012 Jul 22; 82(2):226-34. PubMed ID: 22495291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K, Sun W, Sun J, Sun W, Zhong D, Cao X, Zhou D, Li J.
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb 22; 36(2):99-102. PubMed ID: 25778882
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report.
    Adachi M, Kitamura M, Muta K, Maekawa A, Uramatsu T, Tadokoro M, Funakoshi S, Hisano S, Kuwahara N, Shimizu A, Mukae H, Nishino T.
    BMC Nephrol; 2020 May 24; 21(1):195. PubMed ID: 32448180
    [Abstract] [Full Text] [Related]

  • 16. Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition.
    Li D, Liu D, Xu H, Yu XJ, Zhou FD, Zhao MH, Wang SX.
    BMC Nephrol; 2019 Dec 23; 20(1):476. PubMed ID: 31870425
    [Abstract] [Full Text] [Related]

  • 17. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y, Zhang Y, Zhou X, Xue X, Wang M, Kang D, Zhou Y, Hu R, Quan S, Xing G, Yang J.
    BMC Nephrol; 2023 Mar 10; 24(1):50. PubMed ID: 36894904
    [Abstract] [Full Text] [Related]

  • 18. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S, Theis JD.
    J Nephrol; 2018 Jun 10; 31(3):343-350. PubMed ID: 28828707
    [Abstract] [Full Text] [Related]

  • 19. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
    Paueksakon P, Fogo AB, Sethi S.
    Hum Pathol; 2014 Jul 10; 45(7):1445-50. PubMed ID: 24792621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.